As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

According to doctors, making a misstep is easier than you may think.

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.

Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn’t studying weight loss. Roche plans to launch Phase 3 studies of its ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

We're seeing a lot more baked goods being sold, baked fish, baked chicken versus the fried option,’ says Michelle Weckstein, ...

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent ...

While Baseline Therapeutics declined to disclose its starting capital, the startup said it will use the funds to push its GLP-1 asset BT-001 into late-stage development, with two trials planned this ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

In today’s Pharmaceutical Executive Daily, Roche reports positive Phase II results for a dual GLP-1/GIP receptor agonist, ...